helixstreet taking part in NVIDIA’s AI inception program
helixstreet is proud to be part of NVIDIA’s inception program for promising AI startups.
New CMA Report regarding Merger ILMN & PACB
Competiton & Markets Authority published a new report regarding the Merger of ILMN & PACB – the reports removes in my humble opinion the existing obstacles of the CMA.
helixstreet on the Swiss Healthcare Startup Leaderboard @ Crunchbase
Dayone 9th September
helixstreet @ https://www.dayone.swiss/dayone/conference.html
helixstreet elected to present @ DayOne Conference
helixstreet is proud to be elected as one of the DayOne Conference startups to present at the Conference.
helixstreet & EPD
helixstreet app allows you to store your DNA in several electronic patient dossiers. For example Swiss customers will be able to store their sequencing data in their Electronic Dossier.
Long read sequencing – a perspective from UK Competition & Markets Authority
The UK Authority’s report regarding the planned merger of ILMN & PACB gives interesting inside views to long read sequencing technology of PACB. helixstreet.com is completely focusing on Long Read sequencing technology.
helixstreet.com – our mobile app
Our helixstreet App is in the making. Imagine your Genome literally in your hands. Show your doctor your DNA. You have symptoms which could be caused by illness A or illness B. With your DNA in your hands your Doctor can “reverse phenotype” and look for which illness you have a predisposition.
SMRT Leiden 2019 Day 2: Evolving Towards Precision Medicine with Longer, Accurate Reads
Long Read Sequenced DNA – as done by helixstreet – is one of the building blocks for precision medicine.
